Strath contains 61 vital substances, from which each body takes what it needs,” says David Pestalozzi. Thirty-five studies of varying influence have been carried out to date. See Research at www.bio-strath.ch
Part 2 Strath (Bio-Stath) Tonic
To read Part 1 published 10 August – scroll this page. Part 3 will be published 13 August:
On today’s edition of Navigating the Cancer Maze, Grace Gawler interviews Dr Horst Lindhoffer PhD about one of the most innovative and exciting cancer immunotherapy treatment breakthroughs in many years. Visit germancancertreatments.com for more information.
On Navigating the Cancer Maze – Cancer Immunotherapy – Ground-breaking treatment in Cancer Medicine Grace Gawler -August 2, 2013
“Destroying cancer stem cells means fighting cancer at its roots”, says Horst Lindhofer, CEO of TRION Pharma. “Catumaxomab’s efficacy against this particularly aggressive and resistant population of cancer cells further supports its therapeutic potential for the treatment of EpCAM-positive carcinomas.”
On today’s edition of Navigating the Cancer Maze, I interview Dr Horst Lindhoffer PhD about one of the most innovative and exciting cancer treatment breakthroughs in many years. We know that The human immune system is usually quite effective at identifying and eliminating abnormal cells.
Cancer cells, however, can form tumors and spread throughout the body. Although chaotic in their behavior, cancer cells operate with high level intelligence to escape detection by our immune system’s control mechanisms. Often misunderstood, this is a fundamental principle in understanding how cancer cells behave and how immune recognition can be assisted. The new breakthrough cancer treatments capitalize on that information. It has been a long-standing vision of physicians and scientists to develop a treatment that can put the immune system back on track. TRION has achieved the goal with its trifunctional Triomab® antibodies. Listen to learn more or contact email@example.com for further details.
Listen to this interview at: http://www.voiceamerica.com/episode/72038/cancer-immunotherapy-ground-breaking-treatment-in-cancer-medicine
Catumaxomab (Removab®) is presently the only approved therapeutic antibody targeting EpCAM, a surface antigen that is widely expressed in the most frequent forms of human cancer. On April 20th this year, Removab® received EU approval for the intraperitoneal treatment of malignant ascites in patients with EpCAM-positive carcinomas. Removab® is the first product world-wide to receive a regulatory approval for this indication. With its trifunctional mode of action, Removab® represents a new generation of antibodies using the body’s own immune system to help fight the tumor cells.
EpCAM: EpCAM or epithelial cell adhesion molecule is a pan-epithelial differentiation antigen that is expressed on almost all carcinomas, such as breast, lung, colorectal, gastric, prostate and ovarian cancer. Catumaxomab (Removab®) is the only approved anti-EpCAM antibody available.
Triomab®: Trifunctional antibodies : Triomab® antibodies bind to cancer-specific surface antigens and recruit both T cells as well as accessory cells, such as macrophages, dendritic cells and natural killer cells, to the tumor site. As a result, they provide for a new quality of cancer cell killing, activating both arms of the immune system – the adaptive one with cytotoxic T cells as effectors and the innate one including accessory effector cells.
Triomab® antibodies are therefore very effective in destroying cancer cells and show a therapeutic effect at very low doses. Triomab® antibodies are a development of TRION Pharma GmbH Catumaxomab was invented by TRION Pharma and has been developed with Fresenius Biotech.
Cancer Patients without Borders Redefining Cancer Outcomes with the New Culture of Cancer Survivorship on the new season of the Grace Gawler Institute’s Navigating the Cancer Maze on Voice America’s Health and Wellness channel.
Voice America Redefining Cancer Outcomes with the New Culture of Cancer Survivorship
Today marks the new season of the Grace Gawler Institute’s Navigating the Cancer Maze on Voice America’s Health and Wellness channel. The show began almost one year ago and serves as an educational tool for cancer patients who want navigate the maze in an eclectic yet informed manner. The show draws from a wide range of presenters who speak from experience and authority on various cancer related topics. The archived programs represent an tremendously helpful encyclopaedia of knowledge that is not in any way in conflict with the thoughts and opinions of all the experts on the show. This means – no confusion and greater clarity for patients. Instead of opposing views and a “this treatment is better that one” approach, these archives serve purpose as a balanced and significant value-ad for any cancer patient navigating the maze. Listen to people close to cancer such as Fran Dresher (ex-the Nanny), Dr Emmett Miller, oncologists, Prof Thomas Vogl, Dr Ioannis Papasotiriou Genetic/molecular medicine, researcher Caryle Hirshberg, recovered patients Debbie Franke Ogg, Bob Ellal, Peter Trayhurn and more. To listen to today’s show or to access archives please visit http://www.voiceamerica.com/show/2125/navigating-the-cancer-maze
Remember to like us on Facebook at Voice America – we lost many thousands of show “likes” this year to cyber gremlins!
Please pass this resource on to people who are dealing with cancer – MP3 downloads for ipod/ipad are a great gift to take to someone in hospital where there is often a lot of idle time. Cancer patients spend so much of their valuable and precious lives waiting to see health professionals, so MP3’s on ipod/ipad are also great for use in waiting rooms. Please visit Voice America’s Health and wellness Channel to listen to recent or archived shows located on the right side of the my Voice America webpage. The show is free to air and I believe it is one of the most effective ways to educate cancer patients as it has the potential to be heard by millions and change old fear based models that surround cancer into new paradigms of authentic hope and a new Culture of Cancer Survivorship. For resources please visit our new shop at www.germancancertreatments.com also visit www.gracegawlerinstitute.com for more information.
Navigating the Cancer Maze on Voice America’s Health and Wellness Channel
Welcome to the new season of navigating the Cancer maze…..Today’s show will present an overview of our past editions and some key learning’s from our past guests. This seasons show promises to provide you with even more food for thought regarding how to effectively navigate the cancer maze. Importantly, we mark a new era; what we call the New Culture of Cancer Survivorship. What is this new culture about and how will it impact cancer patients. This new show is sponsored by the Grace Gawler Institute for Integrated Cancer Solutions – a Global entity offering unique personalised services to cancer patients. Today we will also talk about the Grace Gawler Institute’s Cancer Patients without Borders Medi-tours and how those tours are impacting cancer patients and treatment outcomes.